{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 2645"}, "official-title": {"#tail": "\n\t", "#text": "To provide access to medication-assisted therapy, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140723", "#text": "July 23, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}, "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Markey", "@name-id": "S369"}, "cosponsor": [{"#tail": ", ", "#text": "Mrs. Feinstein", "@name-id": "S221"}, {"#tail": ", ", "#text": "Mr. Rockefeller", "@name-id": "S176"}, {"#tail": ", ", "#text": "Mr. Brown", "@name-id": "S307"}, {"#tail": ", and ", "#text": "Ms. Hirono", "@name-id": "S361"}, {"#tail": ") introduced the following bill; which was read twice and referred to the ", "#text": "Mr. Durbin", "@name-id": "S253"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "This Act may be cited as the\n\t\t  ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "quote": [{"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Recovery Enhancement for Addiction Treatment Act", "@value": "Recovery Enhancement for Addiction Treatment Act", "@proposed": "true"}, "#text": "\n              "}, "#tail": " or the ", "#text": "\n          "}, {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "TREAT Act", "@value": "TREAT Act", "@proposed": "true"}, "#text": "\n            "}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "Congress finds the following:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Overdoses from opioids have increased dramatically in the United States."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id59e8149eee5c4ea7a9955fba964201f2", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Deaths from drug overdose, largely from prescription pain relievers, have tripled among men and\n\t\t\t increased five-fold among women over the past decade."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "id62042d8e55014162b67c973dd4e4a0be", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Nationwide, drug overdoses now claim more lives than car accidents."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "id3499fbe223f3458b8972a07d97d77a72", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Opioid addiction is a chronic disease that, untreated, places a large burden on the healthcare\n\t\t\t system.  Roughly 475,000 emergency room visits each year are attributable\n\t\t\t to the misuse and abuse of opioid pain medication."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "idfc80d4b2020a4346b19230bc6be311ab", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Effective medication-assisted treatment for opioid addiction can decrease overdose deaths, be\n\t\t\t cost-effective, reduce transmissions of HIV and viral hepatitis, and\n\t\t\t reduce other social harms such as criminal\n\t\t\t activity."}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "id53b1cea0517f429598c00e12fea8d62d", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Effective medication-assisted treatment programs for opioid addiction should include multiple\n\t\t\t components, including medications, cognitive and behavioral supports and\n\t\t\t interventions, and\n\t\t\t drug testing."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "id3006bfee5f174b819c918397432165be", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Effective medication-assisted treatment programs for opioid addiction may use a team of staff\n\t\t\t members, in addition to a prescribing provider, to deliver comprehensive\n\t\t\t care."}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "idA97B94154B6F4E3390EEB58346BC2BD8", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Access to medication-assisted treatments, including office-based buprenorphine opioid treatment,\n\t\t\t remains limited in part due to current practice regulations and an\n\t\t\t insufficient number of providers."}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "@id": "id8c02762f803249a39961a68810001932", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "More than 10 years of experience in the United States with office-based buprenorphine opioid\n\t\t\t treatment has informed best practices for delivering successful, high\n\t\t\t quality care."}, "enum": {"#tail": "\n        ", "#text": "(9)"}, "@id": "id0cdfa82d928448d79cb8fe20158f5a35", "#text": "\n        "}], "#text": "\n      ", "@id": "id2f389d28114840cea82c9a68aec6e2ee"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "  is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 303(g)(2)(B) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:B"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.  823(g)(2)(B)", "@value": "usc/21/823/g/2/B"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Expansion of patient limits under waiver"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "clause (i)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:B/cl:i"}, "term": [{"#tail": " and inserting ", "#text": "physician"}, {"#tail": ";", "#text": "practitioner"}], "#text": "in "}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "idcbb4920bd9b948598e70ccce5f89b518", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "clause (iii)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:B/cl:iii"}, "#text": "in "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "#text": "\n        ", "@id": "id3c8bd7de8bf74016a0fd1e6ba6468cd9", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting ", "#text": "30"}, {"#tail": ";  and", "#text": "100"}], "#text": "by striking "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "idFD1661D7D73143B6B6DD94F6DCE3E44E", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "quote": {"#tail": " and all that follows through the end and inserting a period; and", "#text": ", unless, not sooner"}, "#text": "by striking "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "id7BC48357C70847788D087CB1DC4CA5F8", "#text": "\n          "}]}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "#text": "by inserting at the end the following new clause:"}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "clause": {"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the qualifying practitioner may submit a second\n\t\t\t notification to\n\t\t\t the ", "@entity-type": "act", "#text": "clause (iii)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:B/cl:iii"}, {"#tail": " of the need and intent of the qualifying practitioner to\n\t\t\t treat an unlimited number of patients, if the qualifying\n\t\t\t practitioner\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not earlier than 1 year after the date on which a qualifying practitioner obtained an initial\n\t\t\t waiver\n\t\t\t pursuant to "}, "enum": {"#tail": "\n            ", "#text": "(iv)"}, "subclause": [{"#tail": "\n            ", "item": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "item (aa)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:aa", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(bb)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:bb", "@proposed": "true"}, {"#tail": ", or ", "@entity-type": "act", "#text": "(cc)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:cc", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "(dd) of subparagraph (G)(ii)(I)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:dd", "@proposed": "true"}], "#text": "satisfies the requirements of "}, "enum": {"#tail": "\n                ", "#text": "(aa)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "id5CB857F2EDF346F49903F666E7A2F386", "@commented": "no"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "agrees to fully participate in the Prescription Drug Monitoring Program of the State in which the\n\t\t\t qualifying practitioner is licensed, pursuant to\n\t\t\t applicable State guidelines; or"}, "enum": {"#tail": "\n                ", "#text": "(bb)"}, "#text": "\n                ", "@id": "idf3285b936318497996280629933197df"}], "enum": {"#tail": "\n              ", "#text": "(I)"}, "@id": "id83ffb943d4be4437891911c30f7b5766", "#text": "\n              "}, {"#tail": "\n          ", "item": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "item (ee)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:ee", "@proposed": "true"}, {"#tail": ", or ", "@entity-type": "act", "#text": "(ff)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:ff", "@proposed": "true"}, {"#tail": ";", "@entity-type": "act", "#text": "(gg) of subparagraph (G)(ii)(I)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:gg", "@proposed": "true"}], "#text": "satisfies the requirements of "}, "enum": {"#tail": "\n                ", "#text": "(aa)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "id170D7A1D0A2345678B33D35AFF957F03", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "agrees to fully participate in the Prescription Drug Monitoring Program of the State in which the\n\t\t\t qualifying practitioner is licensed, pursuant to\n\t\t\t applicable State guidelines;"}, "enum": {"#tail": "\n                ", "#text": "(bb)"}, "#text": "\n                ", "@id": "id2729603758f742c49f62af886a3070cc"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "practices in a qualified practice setting; and"}, "enum": {"#tail": "\n                ", "#text": "(cc)"}, "#text": "\n                ", "@id": "id583b4ab5361745cf89f10e3fd31ec141"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines is appropriate for\n\t\t\t purposes of this subclause.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "has completed not less than 24 hours of training (through classroom situations, seminars at\n\t\t\t professional society meetings, electronic communications, or otherwise)\n\t\t\t with respect to the treatment and management of opiate-dependent patients\n\t\t\t  for substance use disorders provided by the American Society of Addiction\n\t\t\t Medicine, the American\n\t\t\t Academy of Addiction Psychiatry, the American Medical Association, the\n\t\t\t American Osteopathic Association, the American Psychiatric Association, or\n\t\t\t any other organization that the "}, "enum": {"#tail": "\n                ", "#text": "(dd)"}, "#text": "\n                ", "@id": "id44FD06DB3ED6472282ADE68C65859397"}], "enum": {"#tail": "\n              ", "#text": "(II)"}, "@id": "id14ec281f95144bc89c0ee46ebb92d50b", "#text": "\n              "}], "#text": "\n            ", "@id": "id6592a3e7d7fb49c1bfb20f56d6c31d16"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id8ca14fc5c97f467487db76e3318e05c7"}, "#text": "\n        ", "@id": "id26448ce924134d678990b32842b79fcd"}], "#text": "\n      ", "@id": "id3d123a5bab544c7fb641214ed34e3590"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 303(g)(2)(G) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 823(g)(2)(G)", "@value": "usc/21/823/g/2/G"}, "@parsable-cite": "usc/21/823", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and inserting the following:", "@entity-type": "act", "#text": "clause (ii)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii"}, "#text": "by striking ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "; and"}, "#tail": "\n      ", "clause": {"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n            ", "term": {"#tail": " means the following:", "#text": "qualifying practitioner"}, "#text": "The term "}, "enum": {"#tail": "\n            ", "#text": "(ii)"}, "subclause": [{"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "A physician who is licensed under State law and who meets 1 or more of the following conditions:"}, "enum": {"#tail": "\n              ", "#text": "(I)"}, "item": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "The physician holds a board certification in addiction psychiatry from the American\n\t\t\t Board of Medical Specialties."}, "enum": {"#tail": "\n                ", "#text": "(aa)"}, "@id": "idaeb6c7b58d7d4dd184d807a49e8ad335", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "The physician holds an addiction certification from the American Society of Addiction Medicine."}, "enum": {"#tail": "\n                ", "#text": "(bb)"}, "@id": "id83840ebe7fbe415b8026d75619cc961c", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "The physician holds a board certification in addiction medicine from the American\n\t\t\t Osteopathic Association."}, "enum": {"#tail": "\n                ", "#text": "(cc)"}, "@id": "id5229649fac634ed6bc43df8fe13bbb0f", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "The physician holds a board certification from the American Board of Addiction\n\t\t\t Medicine."}, "enum": {"#tail": "\n                ", "#text": "(dd)"}, "@id": "id4a408f3b6d4548a9a70ecd25c53e1ddd", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t determines is appropriate for purposes of this subclause.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The physician has completed not less than 8 hours of training (through classroom situations,\n\t\t\t seminar at professional society meetings, electronic communications, or\n\t\t\t otherwise) with respect to the treatment and management of\n\t\t\t opiate-dependent patients for substance use disorders provided by the\n\t\t\t American Society of Addiction\n\t\t\t Medicine, the American Academy of Addiction Psychiatry, the American\n\t\t\t Medical Association, the American Osteopathic Association, the American\n\t\t\t Psychiatric Association, or any other organization that the "}, "enum": {"#tail": "\n                ", "#text": "(ee)"}, "@id": "ida3f59fa9fd2e4b63a0fc7f702def88c4", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " by this sponsor of such approved drug.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The physician has participated as an investigator in 1 or more clinical trials leading to the\n\t\t\t approval of a narcotic drug in schedule III, IV, or V for maintenance or\n\t\t\t detoxification treatment, as demonstrated by a statement submitted to the\n\t\t\t "}, "enum": {"#tail": "\n                ", "#text": "(ff)"}, "@id": "id742a9e6274b448879cc18b5749f387e6", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines will demonstrate\n\t\t\t the ability of the physician to treat and manage opiate-dependent\n\t\t\t patients.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The physician has such other training or experience as the "}, "enum": {"#tail": "\n                ", "#text": "(gg)"}, "@id": "idda0b59fdbc734051bf6a91ad06c14100", "#text": "\n                "}], "#text": "\n              ", "@id": "id7343ee8db9434ee7bf067065f65a21ce"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "A nurse practitioner or physician assistant who is licensed under State law and meets all of the\n\t\t\t following conditions:"}, "enum": {"#tail": "\n              ", "#text": "(II)"}, "item": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "The nurse practitioner or physician assistant is licensed under State law to prescribe schedule\n\t\t\t III, IV, or V medications for pain."}, "enum": {"#tail": "\n                ", "#text": "(aa)"}, "@id": "id4a2a432bce1f4c1e9a369d6c1cb9dd33", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "The nurse practitioner or physician assistant satisfies 1 or more of the following:"}, "enum": {"#tail": "\n                ", "#text": "(bb)"}, "subitem": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines is appropriate for\n\t\t\t purposes of this subclause.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Has completed not fewer than 24 hours of training (through classroom situations, seminar at\n\t\t\t professional society meetings, electronic communications, or otherwise) \n\t\t\t with respect to the treatment and management of opiate-dependent patients\n\t\t\t for substance use disorders provided by the American Society of Addiction\n\t\t\t Medicine, the American\n\t\t\t Academy of Addiction Psychiatry, the American Medical Association, the\n\t\t\t American Osteopathic Association, the American Psychiatric Association, or\n\t\t\t any other organization that the "}, "enum": {"#tail": "\n                  ", "#text": "(AA)"}, "@id": "id2af3bfacd8664c30819bf11665605b3c", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines will demonstrate the ability of\n\t\t\t the nurse practitioner or physician assistant to treat and manage\n\t\t\t opiate-dependent patients.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Has such other training or experience as the "}, "enum": {"#tail": "\n                  ", "#text": "(BB)"}, "@id": "id801c88d287c7446da023ddab36bc32ff", "#text": "\n                  "}], "#text": "\n                ", "@id": "ide839ef0cfcb247a9aab5a8045bfba826"}, {"#tail": "\n            ", "text": {"#tail": "\n                ", "#text": "The nurse practitioner or physician assistant practices under the supervision of a licensed\n\t\t\t physician who holds an active waiver to prescribe schedule III, IV, or V\n\t\t\t narcotic medications for opioid addiction therapy, and\u2014"}, "enum": {"#tail": "\n                ", "#text": "(cc)"}, "subitem": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "item (aa)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:aa", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(bb)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:bb", "@proposed": "true"}, {"#tail": ", or ", "@entity-type": "act", "#text": "(cc)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:cc", "@proposed": "true"}, {"#tail": "; or", "@entity-type": "act", "#text": "(dd) of subclause\n\t\t\t (I)", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:G/cl:ii/scl:I/i:dd", "@proposed": "true"}], "#text": "the supervising physician satisfies the conditions of "}, "enum": {"#tail": "\n                  ", "#text": "(AA)"}, "@id": "idd17eaae068cb4315b6be83a6dc4a7dce", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "both the supervising physician and the nurse practitioner or physician assistant practice in a\n\t\t\t qualified practice setting."}, "enum": {"#tail": "\n                  ", "#text": "(BB)"}, "@id": "id09a7def18fea4de3822e6f18b828c8fa", "#text": "\n                  "}], "#text": "\n                ", "@id": "idd6d75299f75a444385e13cec585339a0"}], "#text": "\n              ", "@id": "idf3e6653dd2a444308c0b3f441011125e"}, {"#tail": "\n          ", "text": {"#tail": "\n              ", "#text": "A nurse practitioner who is licensed under State law and meets all of the following conditions:"}, "enum": {"#tail": "\n              ", "#text": "(III)"}, "item": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "The nurse practitioner is licensed under State law to prescribe schedule III, IV, or V medications\n\t\t\t for pain."}, "enum": {"#tail": "\n                ", "#text": "(aa)"}, "@id": "idaac3982466c74f6ab4e5d6c6dfdb4119", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines demonstrates\n\t\t\t specialization in the ability to treat opiate-dependent patients, such as\n\t\t\t a certification in addiction specialty accredited by the American Board\n\t\t\t of Nursing Specialties or the National Commission for Certifying\n\t\t\t Agencies,  or a certification in addiction nursing as a Certified\n\t\t\t Addiction Registered Nurse\u2014Advanced Practice.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The nurse practitioner has training or experience that the "}, "enum": {"#tail": "\n                ", "#text": "(bb)"}, "@id": "id23e7976183d045b092ca81fb4493e13d", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "In accordance with State law, the nurse practitioner prescribes opioid addiction therapy in\n\t\t\t collaboration with a physician  who holds an active waiver to prescribe\n\t\t\t schedule III, IV, or V narcotic medications for opioid addiction therapy."}, "enum": {"#tail": "\n                ", "#text": "(cc)"}, "@id": "ide668e06648184a1f90b67db7ac1b61bb", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "The nurse practitioner practices in a qualified practice setting."}, "enum": {"#tail": "\n                ", "#text": "(dd)"}, "@id": "id66e4007f038d412b979d911784caa19e", "#text": "\n                "}], "#text": "\n              ", "@id": "id69e1b8a1086e49a5b83e93808c75bcee"}], "#text": "\n            ", "@id": "idca301b394f5e4002976257ac78ba4fc9"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id9F77D4FC3C1A4D4DB937712DD479E576"}, "#text": "\n        ", "@id": "id5333DFFCFC174F43A1EDBDB7D012B6F1"}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "clause": {"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n            ", "term": {"#tail": " means 1 or more of the following treatment settings:", "#text": "qualified practice setting"}, "#text": "The term "}, "enum": {"#tail": "\n            ", "#text": "(iii)"}, "subclause": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "A National Committee for Quality Assurance-recognized Patient-Centered Medical Home or\n\t\t\t Patient-Centered Specialty Practice."}, "enum": {"#tail": "\n              ", "#text": "(I)"}, "@id": "id8e922219552843c38489ac4a99cc84be", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "-recognized Accountable Care Organization.", "@entity-type": "federal-body", "#text": "Centers for Medicaid & Medicare Services", "@entity-id": "7530"}, "#text": "A "}, "enum": {"#tail": "\n              ", "#text": "(II)"}, "@id": "id70bdc5df4dfe428fa6f3235c45ddcc35", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "federal-body", "#text": "Department of Veterans Affairs", "@entity-id": "3600"}, {"#tail": ", or\n\t\t\t ", "@entity-type": "federal-body", "#text": "Department of Defense", "@entity-id": "9700"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Indian Health Service", "@entity-id": "7527"}], "#text": "A clinical facility administered by the "}, "enum": {"#tail": "\n              ", "#text": "(III)"}, "@id": "id1be92665fcd844b5a3154ca3dc52a1fb", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "A Behavioral Health Home accredited by the Joint Commission."}, "enum": {"#tail": "\n              ", "#text": "(IV)"}, "@id": "idC21A44D879824EE6A64373E819DC7EF9", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "A Federally-qualified health center (as defined in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") or\n\t\t\t a Federally-qualified health center look-alike.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t (", "@entity-type": "act", "#text": "section 1905(l)(2)(B) of the Social Security Act", "@value": "Social Security Act/s:1905/ss:l/p:2/sp:B"}, "@entity-type": "law-citation", "#text": "\n                  ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "42 U.S.C. 1396d(l)(2)(B)", "@value": "usc/42/1396d/l/2/B"}, "@parsable-cite": "usc/42/1396d", "#text": "\n                  ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n              ", "#text": "(V)"}, "@id": "id596cec151a65401ba1ef50e3a92e406d", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "A Substance Abuse and Mental Health Services-certified Opioid Treatment Program."}, "enum": {"#tail": "\n              ", "#text": "(VI)"}, "@id": "id4144c5708c98441f988b650986dbc7cf", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "A clinical program of a  State or Federal jail, prison, or other facility where individuals are\n\t\t\t incarcerated."}, "enum": {"#tail": "\n              ", "#text": "(VII)"}, "@id": "idf66615e3f6414ba3881378101e568e71", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "A clinic that demonstrates compliance with the Model Policy on\n\t\t\t DATA 2000 and Treatment of Opioid Addiction in the Medical Office issued\n\t\t\t by the Federation of State Medical Boards."}, "enum": {"#tail": "\n              ", "#text": "(VIII)"}, "@id": "idc83f5fe03d4545c1a8aabef9211e5ff5", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "A treatment setting that is part of an Accreditation Council for Graduate Medical Education,\n\t\t\t American\n\t\t\t Association of Colleges of Osteopathic Medicine, or American\n\t\t\t Osteopathic Association-accredited residency or fellowship training\n\t\t\t program."}, "enum": {"#tail": "\n              ", "#text": "(IX)"}, "@id": "id6e5104c9f20849dcab42c7cf832d6956", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "Any other practice setting approved by a State regulatory board or State Medicaid Plan to provide\n\t\t\t addiction treatment services."}, "enum": {"#tail": "\n              ", "#text": "(X)"}, "@id": "id9b41d686fbd945a98cc76f84953935ce", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary"}, "#text": "Any other practice setting approved by the "}, "enum": {"#tail": "\n              ", "#text": "(XI)"}, "@id": "idecf8e30390a44624b4666448931c1b6b", "#text": "\n              "}], "#text": "\n            ", "@id": "ide0ddee510edd41f3b566ae42eae343ca"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "id131824DD20CB4AFAB984CC8044C0D22C"}, "#text": "\n        ", "@id": "id1df1998b07824ee1b1477886cfb1ce3d"}], "#text": "\n      ", "@id": "id48764625c37a4611942372465a1d45a9"}, {"#tail": "\n  ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human\n\t\t\t Services", "@entity-id": "7500"}, {"#tail": " shall initiate an\n\t\t\t evaluation of the\n\t\t\t effectiveness of the  amendments made by this Act, which shall include an\n\t\t\t evaluation of\u2014", "@entity-type": "federal-body", "#text": "Comptroller General of the United States", "@entity-id": "0500"}], "#text": "Two years after the date on which the first notification under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as\n\t\t\t added by this Act,  is received by the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "clause (iv) of section\n\t\t\t 303(g)(2)(B) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303/ss:g/p:2/sp:B/cl:iv", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 823(g)(2)(B)", "@value": "usc/21/823/g/2/B"}, "@parsable-cite": "usc/21/823", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "GAO Evaluation"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "any changes in the availability and use of medication-assisted treatment for opioid addiction;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id33BA2A803D8B4F19998B293D125BF0E5", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "the quality of medication-assisted treatment programs;"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "id29A0097F24134C1CA660F6B9DB4DFED1", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "the integration of medication-assisted treatment with routine healthcare services;"}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "idEAFA93BC7CC5449D89F6FE2D10DB351C", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "diversion of opioid addiction treatment medication;"}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "id1FD57B2D785E41E3922159EBE33738D1", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "changes in State or local policies and legislation relating to opioid addiction treatment;"}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "id91B3E29699E244CF9A767D53B080FE7E", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "the use of nurse practitioners and physician assistants who prescribe opioid addiction medication;"}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "id2E686C8573E2481F907C5A9F0DB05929", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "the use of Prescription Drug Monitoring Programs by waived practitioners to maximize safety of\n\t\t\t patient care and prevent diversion of opioid addiction medication;"}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "id2a8b5709bfa84e9389e44b0cd1becbf9", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " inspections of waived practitioners, including the\n\t\t\t frequency with which the ", "@entity-type": "federal-body", "#text": "Drug Enforcement Agency", "@entity-id": "1524"}, {"#tail": " finds no\n\t\t\t documentation of access to behavioral health services; and", "@entity-type": "federal-body", "#text": "Drug Enforcement Agency", "@entity-id": "1524"}], "#text": "the findings of "}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "@id": "id2f09752bf92c474bab4baec5682fafc2", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t and the ", "@entity-type": "federal-body", "#text": "Department of Health and Human\tServices", "@entity-id": "7500"}, {"#tail": " for expanding effective opioid addiction\n\t\t\t treatment.", "@entity-type": "federal-body", "#text": "Drug Enforcement Agency", "@entity-id": "1524"}], "#text": "the effectiveness of cross-agency collaboration between "}, "enum": {"#tail": "\n        ", "#text": "(9)"}, "@id": "id2551f05351554cc2a0742a3f2c729915", "#text": "\n        "}], "#text": "\n      ", "@id": "id6CEB1E7954C6400B99164C31C1D6A2D7"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-07-23"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2645 IS: TREAT Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}